🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Vilanterol and Fluticasone Furoate

Found 90 matching trials

Pharmacokinetic Study in Healthy Volunteers to Characterise the Exposure of Fluticasone Furoate (FF), Vilanterol (VI) and Umeclidinium (UMEC) at Two Different Doses

PHASE1

This study will evaluate the pharmacokinetics of FF, UMEC and VI administer...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-07-15

Trial ID

NCT01894386

Treatments Being Tested

FF 400 mcg UMEC 500 mcg UMEC 250 mcg VI 100 mcg

Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients: A Randomized Crossover Study

PHASE4

The goal of this clinical trial is to determine if triple inhaled therapy w...

Status

Completed

Location

Narongkorn Saiphoklang

Start Date

2025-04-01

Trial ID

NCT06905483

Treatments Being Tested

Budesonide/Glycopyrronium/Formoterol (BGF)Fluticasone Furoate/Umeclidinium/Vilanterol (FUV)

Urine Concentrations of Vilanterol After Inhaled Administration of Vilanterol/Fluticasone Furoate

PHASE2

Introduction: The prevalence of asthma and exercise-induced bronchoconstric...

Status

Completed

Location

Respiratory research unit, Bispebjerg University Hospital

Start Date

2019-02-08

Trial ID

NCT03739294

Treatments Being Tested

Fluticasone Furoate/ Vilanterol Trifenatate

A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma

PHASE3

A once-daily 'closed' triple FDC therapy of FF/UMEC/VI via a single ELLIPTA...

Status

Completed

Location

GSK Investigational Site

Start Date

2016-10-13

Trial ID

NCT02924688

Treatments Being Tested

FF/UMEC/VI (100/31.25/25) mcg FF/UMEC/VI (100/62.5/25) mcg FF/UMEC/VI (200/31.25/25) mcg FF/UMEC/VI (200/62.5/25) mcg FF/VI (100/25) mcg FF/VI (200/25) mcg Fluticasone/salmeterol (FSC)Albuterol/salbutamol ELLIPTA DPI DISKUS DPI METERED-DOSE INHALER (MDI)

A Study in Asthmatic Patients to Determine if There is Any Difference in Dosing With Fluticasone Furoate/Vilanterol Inhalation Powder in the Morning or Evening on Lung Function

PHASE2

This study will be a repeat-dose, double-blind, randomized, placebo control...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-10

Trial ID

NCT01287065

Treatments Being Tested

FF(100mcg)/Vilanterol(25mcg) AM FF(100mcg)/Vilanterol(25mcg) PM Placebo AM Placebo PM

INvestigating COPD Outcomes, Genomics and Neutrophilic Inflammation With Tiotropium and Olodaterol

PHASE4

This protocol describes a randomised controlled trial to test the hypothesi...

Status

Completed

Location

NHS Tayside

Start Date

2017-06-01

Trial ID

NCT03152149

Treatments Being Tested

Tiotropium & olodaterol fluticasone furoate & vilanterol

A Study in the US Based on Pharmacy and Medical Claims That Compares How Well Stiolto® and Trelegy® Work in People With Chronic Obstructive Pulmonary Disease (COPD)

N/A

This study looks at data from people with chronic obstructive pulmonary dis...

Status

Completed

Location

eMax health

Start Date

2021-12-17

Trial ID

NCT05169424

Treatments Being Tested

Trelegy Ellipta Stiolto Respimat Tiotropium + Olodaterol (5/5 mcg)Fluticasone Furoate + Umeclidinium + Vilanterol (100/62.5/25 mcg)

Study Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD).

PHASE4

This is a multi-center, randomized, double-blind, parallel-group study. The...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-01-28

Trial ID

NCT01957150

Treatments Being Tested

Fluticasone Furoate/Vilanterol Vilanterol

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.

PHASE3

This is a Phase III, multicenter, randomized, double-blind, stratified, par...

Status

Completed

Location

GSK Investigational Site

Start Date

2012-09-20

Trial ID

NCT01686633

Treatments Being Tested

Fluticasone Furoate/ Vilanterol 200/25 mcg Fluticasone Furoate/ Vilanterol 100/25 mcg Fluticasone Furoate 100 mcg

Relovair PD PK in Chinese Healthy Subjects

PHASE1

In this study, fluticasone furoate (FF) and vilanterol (VI) in different do...

Status

Completed

Location

GSK Investigational Site

Start Date

2012-12-05

Trial ID

NCT01711463

Treatments Being Tested

Fluticasone Furoate/Vilanterol Placebo

Previous Next